Am Investment Strategies »

Gt Biopharma shares owned by Am Investment Strategies

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Am Investment Strategies from 13F filings

Historical chart of Am Investment Strategies investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Am Investment Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Am Investment Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $12k 15k 0.80

More positions owned by Am Investment Strategies

Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Us Bancorp Del Com New (USB)
NVIDIA Corporation (NVDA)
Raymond James Financial (RJF)
Asml Holding N V N Y Registry Shs (ASML)
Apollo Global Mgmt (APO)
Sportradar Group Class A Ord Shs (SRAD)
Southern Company (SO)

View all positions for Am Investment Strategies

Top funds holding Gt Biopharma

Scientech Research
SeaCrest Wealth Management
Citadel Advisors
Jane Street
Integrated Wealth Concepts
Geode Capital Management
Coston, McIsaac & Partners
Caitlin John
Wells Fargo & Company
HPM Partners
Am Investment Strategies
Verdence Capital Advisors
Two Sigma Securities
Prospera Financial Services
Hrt Financial

View all funds holding Gt Biopharma